Exscientia Plc - stock earnings

EXAI Quarterly earnings

DateEarningsRevenue
2023Q3 -38.1 million USD 10.8 million USD
2023Q2 -45.4 million USD 3.8 million USD
2023Q1 -46.6 million USD 7.1 million USD
2022Q4 -57.0 million USD 9.9 million USD
2022Q3 -44.0 million USD 7.8 million USD
2022Q2 -24.7 million USD 11.1 million USD
2022Q1 -26.7 million USD 12.0 million USD
2021Q4 -27.2 million USD 5.6 million USD
2021Q3 -9.2 million USD 31.9 million USD
2021Q2 -35.6 million USD 558859 USD
2021Q1 -10.4 million USD 10.0 million USD
2020Q4 -14.2 million USD 8.0 million USD
2020Q3 -13.9 million USD 1.6 million USD
2020Q2 -6.9 million USD 3.0 million USD
2020Q1 -6.9 million USD 3.0 million USD
2019Q4 -2.1 million USD 3.0 million USD
2019Q3 -2.0 million USD 2.8 million USD
2019Q2 -2.0 million USD 2.9 million USD
2019Q1 -2.1 million USD 3.0 million USD

EXAI Yearly earnings

DateEarningsRevenue
2023 -183.3 million USD 31.2 million USD
2022 -173.3 million USD 39.8 million USD
2021 -66.6 million USD 37.1 million USD
2020 -41.5 million USD 18.0 million USD
2019 -10.9 million USD 15.7 million USD

EXAI

Price: $5

52 week price:
3.99
9.12

Earnings Per Share: -1.49 USD

P/E Ratio: -4.02

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 445040

Market Capitalization: 626.8 million

Links: